Cmax is out of the range [Study As­sess­ment]

posted by jag009  – NJ, 2018-08-02 19:56 (2181 d 20:21 ago) – Posting: # 19128
Views: 4,333

Hi,

❝ We recently conducted a BE trial. It was a classical 2-period, 2-sequence study of a drug that consists of a combination of two active substances. Unfortunately, results one of analytes, a parent drug, fell sightly outside of the 80-125% range, below 80% for Cmax. CV was below 30% and post-hoc power was less than 80% for this analyte...


Sorry, there is no way for you to argue.
John

Complete thread:

UA Flag
Activity
 Admin contact
23,117 posts in 4,859 threads, 1,647 registered users;
33 visitors (0 registered, 33 guests [including 8 identified bots]).
Forum time: 16:17 CEST (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5